Status:
COMPLETED
Study Evaluating the Bioavailability of Naproxen 500 mg in Three Formulations
Lead Sponsor:
POZEN
Conditions:
Arthritis
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
We will evaluate the bioavailability of naproxen 500 mg administered as three dfferent formulations.
Eligibility Criteria
Inclusion
- Healthy male or non-pregnant female subjects between 18-55 years of age as well as other standard inclusion criteria for a study of this nature
Exclusion
- Standard exclusion criteria for a study of this nature
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2008
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00665743
Start Date
March 1 2008
End Date
June 1 2008
Last Update
June 10 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Austin, Texas, United States